More than a decade after InfraScan’s technology was initially approved by the FDA to detect internal bleeding in the brains of adult patients with head injuries, the agency has granted an expansion of ...
PHILADELPHIA--(BUSINESS WIRE)--InfraScan, a medical device company specializing in brain injury diagnostic products, announced today that it has obtained U.S. Food and Drug Administration approval to ...
PHILADELPHIA, Aug. 3, 2020 /PRNewswire-PRWeb/ -- InfraScan, a medical device firm specializing in brain injury and stroke diagnostic products, announced today the issuance by the US Patent Office of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback